Novo Nordisk (CSE:NOVOb) (NYSE:NVO) shares slumped Wednesday after Roche (SIX:ROG) struck a $5.3 billion deal to acquire rights to an obesity treatment from Denmark’s Zealand Pharma A/S (CSE:ZELA).
19h
Zacks Investment Research on MSNNVO Stock Slips 4% as Roche Inks Obesity Drug Deal With ZealandNovo Nordisk’s NVO stock declined 4.3% on Wednesday after Roche RHHBY announced a license and collaboration deal worth $5.3 ...
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
To make a direct call to Denmark From New Zealand, you need to follow the international dialing format given below. The dialing format is same for calling Denmark mobile or land line from New Zealand.
From the underdogs to the favorites, this is The Athletic's guide to the 12 teams competing in the fifth SailGP season ...
Transparency International has measured the Corruption Perceptions Index (CPI) in over 170 countries. Sudan is the most corrupt country.
In today’s news, the markets sell-off could get worse, Mike Cannon-Brookes describes his “conflict” over buying a private jet, and Myer is making sweeping changes to its executive team. ASX exits ...
Roche announced that it has struck an exclusive deal with Denmark's Zealand Pharma to develop and market petrelintide, a new treatment for obesity.
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results